See why so many choose Red Bank Infusion Center for their ongoing care, including Bivigam treatments.

Bivigam is biologic therapy that is indicated for treating

  • chronic inflammatory demyelinating polyneuropathy (CIDP)
  • lupus (SLE, systemic lupus erythematosus)
  • multiple sclerosis
  • myasthenia gravis
  • primary immunodeficiencies

Bivigam is an immune globulin made from human blood plasma. Intravenous immune globulin (IVIG) contains antibodies that help protect against infection and inflammation.

Immune globulin is a sterile solution that contains antibodies that protect you against infection from various diseases, and can also treat the inflammation associated with other diseases.

Immune globulin intravenous (IGIV, for injection into a vein) is used to treat primary immunodeficiency.

IGIV is also used to increase platelets (the clotting cells in blood) in people with immune thrombocytopenic purpura.

IGIV is also used in to help prevent certain infections in people with B-cell chronic lymphocytic leukemia.

 

Patients choose Red Bank Infusion Center

to have their Bivigam therapy because

Want to move to
Red Bank Infusion Center?

We make it simple and convenient for you to start your infusion care with us.

Our Mission

To improve the lives of the people we care for by re-imagining the infusion care experience.

Having a chronic illness is difficult to live with, so to have this peaceful, caring environment means more than I can describe. It has really improved my life.

— Tom, Patient 2020

Having a chronic illness is difficult to live with, so to have this peaceful, caring environment means more than I can describe. It has really improved my life.

— Tom, Patient 2020

Let's get started.

If you are interested in moving your infusion treatment to Red Bank Infusion Center, simply request an appointment, and we take care of the rest.

Let's get started.

If you are interested in moving your infusion treatment to Red Bank Infusion Center, simply request an appointment, and we take care of the rest.